No definition available.

Name:	akan_InventoryDetailsScheduleofReconciliationoftheCompanysBiologicalAssetsLineItems
Namespace Prefix:	akan_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

The amount of additions to biological assets resulting from purchases. [Refer: Biological assets]

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 41
-IssueDate 2023-01-01
-Paragraph 50
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2023-en-r&anchor=para_50_b&doctype=Standard
-URIDate 2023-03-23

+ Details

Name:	ifrs-full_AdditionsFromPurchasesBiologicalAssets
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

The amount of current biological assets. [Refer: Biological assets]

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 54
-Subparagraph f
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_f&doctype=Standard
-URIDate 2023-03-23

+ Details

Name:	ifrs-full_CurrentBiologicalAssets
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

The gains (losses) arising from changes in fair value less costs to sell of biological assets due to both physical and price changes in the market. [Refer: Biological assets]

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 41
-IssueDate 2023-01-01
-Paragraph 50
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2023-en-r&anchor=para_50_a&doctype=Standard
-URIDate 2023-03-23

+ Details

Name:	ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:monetaryItemType
Balance Type:	na
Period Type:	duration

- Definition

The increase (decrease) in biological assets resulting from changes that the entity does not separately disclose in the same statement or note. [Refer: Biological assets]

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 41
-IssueDate 2023-01-01
-Paragraph 50
-Subparagraph g
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2023-en-r&anchor=para_50_g&doctype=Standard
-URIDate 2023-03-23

+ Details

Name:	ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesBiologicalAssets
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Details

Name:	ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Inventory (Details) - Schedule of Reconciliation of the Company’s Biological Assets - USD ($)	6 Months Ended		12 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Inventory (Details) - Schedule of Reconciliation of the Company’s Biological Assets [Line Items]
Balance, beginning of the period	$ 809,180
Requisition of raw materials from inventory
Capitalized costs
Loss on change in fair value of biological assets	108,239		1,216,130	(713,135)
Balance, Ending of the period	257,144		809,180
At fair value [member]
Inventory (Details) - Schedule of Reconciliation of the Company’s Biological Assets [Line Items]
Balance, beginning of the period
Requisition of raw materials from inventory				202,900
Capitalized costs				490,672
Loss on change in fair value of biological assets	$ (562,045)		$ 580,411	(693,572)
Balance, Ending of the period